Buy Elocon
Elocon
Elocon Properties
About Elocon
Elocon is a prescription-only topical corticosteroid that contains the potent glucocorticoid mometasone furoate. In Australia it is approved for short-term treatment of inflammatory and pruritic dermatoses such as eczema, psoriasis, and allergic contact dermatitis. The .1 % formulation, supplied in a 5 g tube, delivers anti-inflammatory, immunosuppressive, and vasoconstrictive actions directly to the skin, relieving redness, swelling, and itching. While the primary indication is for skin conditions, clinicians sometimes consider it for off-label uses when conventional therapies fail, always under specialist supervision.
What is Elocon?
Elocon belongs to the class of topical corticosteroids, specifically a medium-to-high-potency glucocorticoid. The Therapeutic Goods Administration (TGA) approved the product in 200 for the management of moderate-to-severe inflammatory skin disorders. As a branded preparation, it is manufactured by GlaxoSmithKline and marketed across Australia in a convenient 5 g tube. The active ingredient, mometasone furoate, is a synthetic analogue of cortisol designed to maximise receptor affinity while minimising systemic absorption when applied correctly. Bioequivalence studies have shown that the branded product delivers the same pharmacological exposure as generic mometasone furoate creams, but Elocon’s formulation provides a smooth, non-greasy texture that many patients prefer.
How Elocon Works
Mometasone furoate exerts its therapeutic effect by binding to intracellular glucocorticoid receptors in keratinocytes and immune cells. Once bound, the receptor complex translocates to the nucleus and modulates gene transcription. Key actions include:
- Inhibition of pro-inflammatory cytokines such as interleukin-1, interleukin-6, and tumor necrosis factor-α, reducing the recruitment of neutrophils and lymphocytes to the skin.
- Suppression of phospholipase A₂, lowering arachidonic-acid-derived prostaglandins and leukotrienes that mediate edema and erythema.
- Vasoconstriction of cutaneous micro-vasculature, which diminishes redness and limits exudate formation.
Pharmacokinetically, mometasone furoate has a high lipophilicity that facilitates penetration into the stratum corneum while limiting systemic uptake. Peak local concentrations are reached within 30-60 minutes, and the anti-inflammatory effect can persist for up to 12 hours, allowing once-daily dosing for most indications. The drug is metabolised primarily by hepatic CYP3A4 after any systemic absorption, and metabolites are excreted in urine. Because systemic exposure is negligible when used as directed, the risk of classic corticosteroid systemic side effects (e.g., adrenal suppression) remains low.
Why Elocon is Used for Skin Conditions
- Eczema (atopic dermatitis) - The drug’s ability to block cytokine release directly addresses the Th2-driven inflammation that characterises eczema, providing rapid itch relief and barrier restoration. TGA guidelines list a medium-potency steroid as first-line for acute flares; Elocon’s potency balances efficacy with a low risk of skin atrophy when limited to ≤2 weeks of use.
- Psoriasis (plaque type) - By suppressing keratinocyte proliferation and inflammatory signaling, mometasone reduces plaque thickness and scaling. Clinical trials comparing mometasone furoate .1 % to lower-potency steroids showed superior Psoriasis Area and Severity Index (PASI) improvement after four weeks of treatment.
- Allergic contact dermatitis - Immediate vasoconstriction curtails the erythema and edema that follow allergen exposure. Elocon’s rapid onset (within an hour) makes it suitable for acute reactions.
- Seborrhoeic dermatitis - The anti-inflammatory action reduces the erythematous component, while the formulation’s oily base helps control scaling on the scalp and face.
- Lichen planus - Though not a first-line agent, topical steroids like Elocon are often employed for localized lesions to diminish the lichenoid infiltrate and pruritus.
In each condition, the drug’s mechanism aligns with the underlying pathophysiology: excessive immune activation and cytokine release drive the clinical signs, and glucocorticoid receptor activation dampens that cascade. Compared with low-potency agents (e.g., hydrocortisone), Elocon offers faster symptom control, while it remains less likely to cause systemic effects than ultra-potent steroids such as clobetasol.
Off-Label and Investigational Uses of Elocon
Some clinicians have explored mometasone furoate for alopecia areata, discoid lupus erythematosus, and vitiligo. Small open-label studies suggest modest hair regrowth in alopecia when combined with topical minoxidil, but evidence remains limited and not endorsed by the TGA. In discoid lupus, short-term use may reduce cutaneous inflammation, yet long-term safety data are sparse. Off-label use should only be considered under the supervision of a qualified healthcare provider, as systemic absorption and disease-specific risks are not fully characterised.
Is Elocon Right for You?
Elocon is most appropriate for adults and adolescents (≥12 years) with moderate-to-severe inflammatory skin diseases that have not responded adequately to low-potency steroids. Ideal candidates can apply the medication to intact skin and are able to adhere to the recommended treatment schedule (usually once daily for up to two weeks). Patients with extensive body-surface involvement, active skin infections, or known hypersensitivity to mometasone should avoid its use. In pregnancy, topical corticosteroids are generally considered safe when limited to small areas, but the TGA advises consultation with a obstetrician before initiating therapy. Likewise, individuals with hepatic or renal impairment are unlikely to experience altered systemic exposure because absorption remains minimal; however, caution is always prudent with prolonged application.
Taking Elocon Effectively
- Timing: Apply a thin layer to the affected area in the evening after a gentle cleanse; this maximises absorption while the skin is slightly damp.
- Quantity: Use the “finger-tip unit” method - one fingertip-sized amount (≈.5 g) is sufficient for an adult’s hand, covering roughly 2 % of body surface. The 5 g tube typically lasts 7-10 days for localized use.
- Occlusion: Do not cover the treated skin with airtight dressings unless directed, as this can dramatically increase systemic absorption.
- Missed dose: If a dose is forgotten, apply it as soon as remembered unless it is close to the next scheduled application; then skip the missed dose to avoid double-dosing.
- Travel: Carry the tube in a sealed plastic bag to protect against temperature extremes; the product remains stable at 15-30 °C for up to two years from the manufacturing date.
- Interactions: Avoid concurrent use of potent topical antifungals or calcineurin inhibitors on the same site, as this may raise irritation risk.
Understanding Side Effects and How to Manage Them
Most adverse reactions are local and result from the drug’s vasoconstrictive and immunosuppressive actions:
- Burning or stinging - Common during the first application; applying a moisturizer 15 minutes after the steroid can soothe the sensation.
- Skin atrophy - Prolonged use (beyond 2 weeks) can thin the epidermis. Rotate treatment sites and limit application to the smallest effective area to minimise this risk.
- Telangiectasia - Visible small blood vessels may develop with chronic use; early detection prompts a treatment break.
- Hypopigmentation - Melanin production can be suppressed; this typically resolves after discontinuation.
- Secondary infection - Because the immune response is dampened, fungal or bacterial overgrowth may occur. If erythema intensifies or pus appears, stop the steroid and seek medical advice.
Serious systemic effects such as adrenal suppression or Cushing-like features are rare but possible with extensive body-surface coverage or inappropriate occlusion. Immediate medical evaluation is warranted if patients experience unexplained weight gain, hypertension, or glucose intolerance while using Elocon.
Buying Elocon from Our Online Pharmacy
Why Choose Our Service?
Our online pharmacy streamlines access to Elocon for Australians who face prescription-only barriers or live in remote areas. By leveraging a secure, licensed supply chain, we ensure that every tube meets Australian regulatory standards.
Quality & Safety
We partner with accredited international pharmacies that operate under stringent Good Manufacturing Practice (GMP) guidelines and are regularly audited by the TGA. All products are shipped in tamper-evident packaging and verified against batch-level authenticity checks.
Pricing & Access
Because Elocon is a brand product, the price can be higher than generic mometasone furoate creams. Through our platform, we negotiate bulk purchasing agreements that translate into up to 30 % savings for customers. A recurring “Lifetime 10 % discount on all reorders” further reduces long-term costs. Alternatives such as generic mometasone are also listed for comparison.
Discreet Delivery
Orders are dispatched within 24 hours, with express shipping averaging 7 days and standard delivery up to 3 weeks. Packages are unbranded and placed in protective envelopes to protect privacy.
Frequently Asked Questions
-
How quickly will I see relief after applying Elocon? Most patients notice a reduction in itching and redness within a few hours, with maximal improvement after 3-5 days of consistent use.
-
Can I use Elocon on my face? Yes, the formulation is safe for facial skin when limited to short-term treatment of localized inflammation. Apply a very thin layer and avoid the eyelid margins.
-
What is the difference between Elocon and generic mometasone cream? Both contain the same active ingredient at an identical concentration. The brand tube offers a non-greasy base that some patients find more comfortable, while generics may have a slightly different vehicle. Clinical efficacy is equivalent.
-
Is it safe to use Elocon while on other topical medications? Concurrent use with other corticosteroids is not recommended due to additive systemic exposure. If you need a combination therapy (e.g., a antifungal), apply each agent at separate times and on distinct skin areas.
-
Will Elocon cause my skin to thin permanently? Skin atrophy is reversible if the medication is discontinued early. Persistent thinning after long-term use usually improves within weeks to months after cessation.
-
Can I apply Elocon after a bath? Applying to slightly damp skin enhances absorption, so a gentle shower followed by pat-drying creates an optimal surface for the medication.
-
Do I need to wash my hands after applying Elocon? Yes, wash your hands thoroughly unless the hands themselves are the treatment site. This prevents accidental transfer to the eyes or mucous membranes.
-
Is pregnancy a contraindication for Elocon? Topical corticosteroids are generally considered low risk in pregnancy when used sparingly. Nonetheless, discuss any planned use with your obstetrician to weigh benefits against potential risks.
-
How should I store the tube? Keep the product in a cool, dry place away from direct sunlight. Do not refrigerate, as this can alter the consistency of the ointment base.
-
What should I do if I miss a dose? Apply the missed dose as soon as you remember, unless the next scheduled dose is imminent; in that case, skip the missed application to avoid doubling the amount.
Glossary
- Glucocorticoid receptor
- A cytoplasmic protein that binds corticosteroids, translocates to the nucleus, and regulates gene transcription influencing inflammation.
- Pharmacokinetics
- The study of how a drug is absorbed, distributed, metabolised, and excreted by the body.
- Atrophy
- Thinning of the skin layer caused by prolonged exposure to potent corticosteroids, leading to decreased collagen synthesis.
- Vasoconstriction
- Narrowing of blood vessels, which reduces blood flow and diminishes redness and swelling in inflamed tissue.
- Occlusion
- The practice of covering a treated skin area with a dressing or barrier, which can increase drug penetration and systemic absorption.
Disclaimer
The information provided about Elocon is for general knowledge only and does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Elocon for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.
